Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth

Pediatric Nephrology

Volumn 22, Issue 7, 2007, Pages 1007-1013

  Retnakaran, Ravi ^a   Connelly, Philip W ^c   Harris, Stewart B ^d   Zinman, Bernard ^a,b   Hanley, Anthony J G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aboriginal youth; Cardiovascular risk factors; Cystatin C; Insulin resistance; Metabolic syndrome

Indexed keywords

CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ABORIGINE; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHILD; CYSTATINS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 34250022252     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0471-9     Document Type: Article

References (36)

1. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A (2005) Cystatin C as a marker of GFR - history, indications and future research. Clin Biochem 38:1-8
2. Shlipak MG, Sarnak MJ, Katz J, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049-2060
3. Sarnak MJ, Katz R, Stehman-Breen C, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG (2005) Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142:497-505
4. O'Hare A, Newman AB, Katz R, Fried LF, Stehman-Breen C, Seliger SL, Siscovick D, Shlipak MG (2005) Cystatin C and incident peripheral arterial disease events in the elderly. Arch Intern Med 165:2666-2670
5. Shlipak MG, Katz R, Sarnak MJ (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237-246
6. Jernberg T, Lindahl B, James S, Larsson A, Hansson L-O, Wallentin L (2004) Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 110:2342-2348
7. Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clin Chem 51:321-327
8. Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA (2006) Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail 12:601-607
9. Ix JH, Shlipak MG, Chertow GM, Whooley MA (2007) Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease. data from the Heart and Soul Study. Circulation 115:173-179
10. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P for PRIME study Group (2006) Plasma cystatin C and development of coronary heart disease: The PRIME study. Atherosclerosis 185:375-380
11. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416-1421
12. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK (1999) Rising tide of cardiovascular disease in American Indians. Circulation 99:2389-2395
13. Shah B, Hux J, Zinman B (2000) Increasing rates of ischemic heart disease in the Native population of Ontario, Canada. Arch Intern Med 160:1862-1866
14. Hanley AJ, Harris SB, Gittelsohn J, Wolever T, Saksvig R, Zinman B (2000) Overweight among children and adolescents in a Native Canadian community. Am J Clin Nutr 71:693-700
15. Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ (2006) Non-traditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr 148:176-182
16. Retnakaran R, Hanley AJ, Connelly PW, Harris SB, Zinman B (2005) Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youth. Can Med Assoc J 173:885-889
17. Li S, Chen W, Srinivasan S, Bond MG, Tang R, Urbina EM, Berenson GS (2003) Childhood cardiovascular risk factors and carotid vascular changes in adulthood. JAMA 290:2271-2276
18. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao XJ, Logan A, Zinman B (1997) The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 20:185-187
19. World Health Organization (1985) Diabetes mellitus: Report of a WHO Study Group. Geneva, World Health Org., (Tech. Rep. Ser. No. 727)
20. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B (2003) Relation of waist circumference and glycemic status to C-reactive protein in Sandy Lake Oji-Cree. Int J Obes 27:347-354
21. Hanley AJ, Harris SB, Gao XJ, Kwan J, Zinman B (1997) Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 20:1408-1415
22. Retnakaran R, Hanley AJ, Connelly WP, Harris SB, Zinman B (2006) Elevated C-reactive protein in Native Canadian children: An ominous early complication of childhood obesity. Diabetes Obes Metab 8:483-491
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
24. Conwell LS, Trost SG, Brown WJ, Batch JA (2004) Indexes of insulin resistance and secretion in obese children and adolescents: A validation study. Diabetes Care 27:314-319
25. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500-e503
26. Gungor N, Saad R, Janosky J, Arslanian S (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47-55
27. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
28. Schwartz GJ, Gauthier B (1985) A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106:522-526
29. de Ferranti S, Gauvreau K, Ludwig D, Neufeld E, Newburger J, Rifai N (2004) Prevalence of the metabolic syndrome in American adolescents. Circulation 110:2494-2497
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486-2497
31. Mitsnefes M, Kimbal T, Kartal J, Kathman T, Mishra J, Devarajan P (2006) Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease. Pediatr Nephrol 21:1293-1298
32. Shlipak MG, Praught ML, Sarnak MJ (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237-246
33. Dyck RF (2001) Mechanisms of renal disease in indigenous populations: influences at work in Canadian indigenous peoples. Nephrology 6:3-7
34. Dyck RF, Tan L (1998) Non-diabetic end-stage renal disease among Saskatchewan Aboriginal people. Clin Invest Med 21:33-38
35. Schuck O, Teplan V, Stollova M, Skibova J (2004) Estimation of glomerular filtration rate in obese patients with chronic renal impairment based on serum cystatin C levels. Clin Nephrol 62:92-96
36. Bokenkamp A, Herget-Rosenthal S, Bokenkamp R (2006) Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol 21:1223-1230